[144] Blackbaud, Inc. SEC Filing
Blackbaud, Inc. (BLKB) filed a Form 144 reporting a proposed sale of 2,500 common shares to be executed through Merrill Lynch on the NASDAQ with an aggregate market value of $159,950. The securities were acquired on 08/01/2025 upon the vesting of a stock award from Blackbaud, Inc., and the transaction is described as a compensatory payment. The approximate date of sale is listed as 08/08/2025. The filing also discloses there were no securities sold by the same person in the prior three months and includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.
- None.
- None.
Insights
TL;DR Small, non-cash compensatory sale from a vested stock award with no recent prior sales reported.
The Form 144 documents a proposed disposition of 2,500 common shares valued at $159,950 through Merrill Lynch on NASDAQ, acquired by vesting on 08/01/2025 and planned for sale on 08/08/2025. Because the filing shows the acquisition was a stock-award vesting and no other sales by the person occurred in the past three months, this appears routine and procedural rather than a signal of material change in company fundamentals. Investors should note the broker, share class, and stated acquisition method as part of standard insider transaction monitoring.
TL;DR Properly documented compensatory sale with required attestation; no immediate governance red flags from the filing alone.
The notice includes the statutory representation that the seller does not possess undisclosed material adverse information and records the transaction as arising from compensatory vesting. The filing names Merrill Lynch as the executing broker and specifies that no other sales were reported in the prior three months. From a governance and disclosure perspective, the Form 144 meets routine reporting expectations; it does not, by itself, indicate governance concerns or material disclosure issues.